Malawi Liverpool Wellcome Clinical Research Programme
Blantyre, Malawi
NCT Number: NCT06807567
The burden of chronic kidney disease (CKD) is rising globally, but disproportionately impacting on low- and middle-income countries (LMIC) including Malawi, which have the fewest resources to manage it. Furthermore, CKD is the leading cause of catastrophic health expenditure worldwide, largely due to the extremely high costs of kidney replacement therapy (KRT) for people with kidney failure. Access to KRT remains limited in many settings, including Malawi, where there is only one nephrologist for a population of over 21 million. It is therefore essential to diagnose and treat CKD in its early stages, to facilitate earlier and more cost-effective treatment to prevent its progression to advanced disease which is associated with increased risks of kidney failure and of cardiovascular morbidity and mortality. CKD is usually asymptomatic in its early stages, so early diagnosis and treatments requires access to key diagnostic tests, in addition to strategies for channelling resources to those at the highest risk.
The causes of CKD are diverse, particularly in LMIC settings where the increasing prevalence of non-communicable diseases intersects with ongoing high burdens of infectious diseases, malnutrition, and many other social and environmental determinants of kidney health. The World Health Organization recommends integrated approaches to improve equity of quality care for people living with long-term conditions, and CKD would be amenable to integrated approaches, however CKD has been neglected from global NCD agendas and there is little data to guide the most effective methods for integrating its care with other long-term conditions (such as hypertension, diabetes and HIV infection), particularly in low-income settings such as Malawi.
The aim of this study is to explore current experiences of care for CKD and related long-term conditions, and to qualitatively evaluate the acceptability and feasibility of different potential approaches to integrating their care, amongst different stakeholders groups in Malawi.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Blantyre, Malawi
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients:
Caregivers:
Healthcare workers:
Policy makers
Exclusion criteria
The patient participants are people who are already receiving healthcare for CKD and/or hypertension, diabetes, HIV, heart failure and/or stroke at one of the named study sites, for at least 6 months prior to recruitment into this qualitative study. The caregiver participants are caregivers for patients meeting these criteria.
The healthcare worker participants are all providing care to patients with long-tem conditions, at one of the names study sites
The policy makers recruited to this study will be individuals involved in policy making for long-term conditions in Malawi
Time frame: 6 months from end of data collection
The outcomes of this study will be the codes and themes identified through thematic analysis of the interview and focus group discussion transcripts.
Trial opening soon.
Get NotifiedLiverpool School of Tropical Medicine
Other
Understanding Risk Factors for Progressive Chronic Kidney Disease in Malawi to Inform Interventions for Earlier Detection ad Prevention (Impso Study)
Acronym: Impso
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06944236
Cardiovascular Diseases, Chronic Disease
Gaziantep, Turkey (Türkiye)
View Trial DetailsNCT06855992
Chronic Disease, Chronic Kidney Disease(CKD)
View Trial DetailsNCT06879223
Chronic Disease, Chronic Kidney Disease(CKD)
Giza, Egypt
View Trial DetailsNCT06865456
Chronic Disease, Chronic Kidney Disease(CKD)
View Trial Details